Research Article | Open Access
Junzui Li, Bin Zhao, Cui Yang, Qionghua Chen, "Construction of a MicroRNA-mRNA Network Underlying Decidualized Endometriotic Cyst Stromal Cells Using Bioinformatics Analysis", BioMed Research International, vol. 2020, Article ID 9246868, 12 pages, 2020. https://doi.org/10.1155/2020/9246868
Construction of a MicroRNA-mRNA Network Underlying Decidualized Endometriotic Cyst Stromal Cells Using Bioinformatics Analysis
Background. Decidualization of ectopic endometrium often leads to the extensive proliferation of local tissue and is easily misdiagnosed as malignant tumors. The study is aimed at constructing a microRNA- (miRNA-) mRNA network underlying decidualized endometriotic cyst stromal cells (ECSCs). Methods. All data were collected from the Gene Expression Omnibus (GEO) database. Firstly, the differentially expressed genes (DEGs, adj. , | log FC | ≥1) and miRNAs (DEMs, , ) were analyzed by the limma package. Secondly, we predicted the target genes (TGs) of these DEMs through the TargetScan, miRDB, and miRTarBase databases. The overlapping genes between DEGs and TGs were screened out. Thirdly, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) enrichment analyses of the overlapping genes were performed for integrated discovery, visualization, and annotation. Then, the protein-protein interaction (PPI) network of the overlapping genes was conducted by the STRING database. Finally, we combined the PPI network and the miRNA-mRNA pairs to build a miRNA-mRNA network. Results. There are 29 DEMs and 523 DEGs. Fourteen overlapping genes were screened out, and these genes were significantly enriched in metabolism and immunity. What is more, a miRNA-mRNA network, including 14 mRNAs and 9 miRNAs, was successfully constructed. Conclusions. Taken together, the miRNA-mRNA regulatory networks described in this study may provide new insights in the decidualization of ECSCs, suggesting further investigations in novel pathogenic mechanisms.
Endometriosis (EMS) is defined as the presence of endometrial glands and stroma in an abnormal or ectopic location outside the uterine cavity. It occurs in approximately 6–10% of reproductive aged women and is present in 20–50% in women with infertility and 71–87% in women with chronic pelvic pain . Meanwhile, the decidualization of endometrial tissue during pregnancy plays an accurate role in the regulation of blastocyst implantation, placenta formation, and maintenance of normal pregnancy. Defects of decidualization can affect trophoblast invasion of the endometrium and may lead to infertility, recurrent spontaneous abortion (RSA), intrauterine growth retardation (IUGR), preeclampsia, premature birth, and other diseases . Importantly, as to patients with EMS, ectopic endometrial decidualization during pregnancy can lead to significant growth of local tissue, which is easily misdiagnosed as malignant tumors . Therefore, understanding the molecular biological mechanism of ectopic endometrium decidualization is helpful for the differential diagnosis of these two diseases.
As we all know, decidualization is a physiological process involving the function and morphological changes of endometrial stromal cells and the reconstruction of extracellular matrix . However, in EMS, the decidualization of the endometrium is a heterogeneous pathological process, including the decidualization of the eutopic endometrium and the decidualization of the ectopic endometrium. Previous studies have shown that the process of endometrial decidualization in patients with EMS may involve the regulation of multiple genes and cell signaling pathways [5, 6]. Su et al. suggested decreasing Notch pathway signaling in the endometrium of women with EMS can impair decidualization of the eutopic endometrium . Cho et al. pointed out that reducing Akt activity and FOXO3a expression in human endometrial stromal cells can inhibit decidual formation of the eutopic endometrium . These studies on decidualization focused on the eutopic endometrial tissue. However, there are few studies on the mechanism of ectopic endometrial decidualization in EMS patients.
Nowadays, many microarray studies have shown that miRNAs are differentially expressed in eutopic endometrial tissues with EMS and ectopic endometrial tissues with EMS . However, so far, there are few reports on genes, miRNAs, and cell signaling pathways related to ectopic endometrial decidualization. The mechanism of these differentially expressed miRNAs in the process of ectopic endometrial decidualization remains unclear. Therefore, the research on miRNAs in the pathogenesis of EMS will be of great significance. As to patients with EMS, potential important candidate genes, miRNAs, and signaling pathways related to ectopic endometrial decidualization need to be identified. Understanding the physiological process of ectopic endometrial decidualization is helpful for the early diagnosis of EMS and the treatment of infertility caused by EMS.
The microarray data of GSE75423 and GSE75422 have been previously used to reveal the mRNA and miRNA expression profiles in decidualized and nondecidualized endometriotic cyst stromal cells (ECSCs) . Herein, we constructed a miRNA-mRNA network and performed Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) enrichment analyses. This study is aimed at identifying the miRNA-mRNA network in decidualized and nondecidualized ECSCs. The workflow of this study is shown in Figure 1(a).
2. Materials and Methods
2.1. Microarray Data
We use the keywords of “endometriosis” and “decidualization” to retrieve data sets about ectopic endometriosis and decidualization in GEO database, which is created and maintained by NCBI. Then, the microarray data of GSE75423 (mRNAs, 4 untreated ECSCs and 4 decidualized ECSCs; Platforms: GPL13497, Agilent-026652 Whole Human Genome Microarray 4x44K v2) and GSE75422 (miRNAs, 4 untreated ECSCs and 4 decidualized ECSCs; Platforms: GPL18402, Agilent-046064 Unrestricted_Human_miRNA_V19.0 Microarray) were collected and downloaded for further analysis.
2.2. Identification of DEMs and DEGs
limma is a package that offers a comprehensive solution for the analysis of gene expression data and used for differentially expressed gene detection . Herein, our datasets were normalized and analyzed by limma package built in R software. As to DEGs, the adj. and |log FC| were set at <0.05 and ≥1 (decidualized ECSCs vs. untreated ECSCs). As to DEMs, the and |log FC| were set at <0.05 and ≥1. Finally, the DEMs and DEGs were used in the next analysis.
2.3. miRNA Target Gene Prediction
The miRNA-mRNA pairs were predicted via miRDB (version 7.0; http://mirdb.org/), miRTarBase (http://mirtarbase.mbc.nctu.edu.tw/index.html) and TargetScan (Version 7.2; http://targetscan.org/vert_72/) databases. Genes that appeared in all three databases were regarded as target genes of DEMs (TGs). miRDB is an online database for miRNA target prediction and functional annotations. All the targets in miRDB were predicted by a bioinformatics tool, MirTarget, which was developed for analyzing thousands of miRNA-target interactions from high-throughput sequencing experiments. miRTarBase is a database of experimentally validated microRNA targets. TargetScan predicts biological targets of miRNAs by searching for the presence of conserved 8 mer, 7 mer, and 6 mer sites that match the seed region of each miRNA.
2.4. Screening of Overlapping Genes
By comparing the predicted TGs of DEMs with DEGs, only the overlapping genes and their interaction pairs were selected and be used to construct a miRNA-mRNA network.
2.5. Go and KEGG Pathway Enrichment Analysis of Overlapping Genes
GO is widely used in annotating genes, gene products, and sequences. KEGG is a comprehensive database for biological interpretation of genome sequences and other high-throughput data. In order to depict the features of the overlapping genes, the GO and KEGG pathway enrichment analysis of overlapping genes were performed by clusterProfiler R package with the criterion: value < 0.05.
2.6. Construction of miRNA-mRNA Network
The online database of STRING (https://string-db.org/) was applied to assess the PPI containing direct (physical) and indirect (functional) associations. We uploaded the overlapping genes to STRING database, and the PPI networks were visualized by Cytoscape software. The minimum required interaction score in STRING Datasets is 0.4. Furthermore, we also used Cytoscape software to visualize the miRNA-mRNA pairs. Lastly, we combined the PPI network and the miRNA-mRNA pairs to build a miRNA-mRNA network.
3.1. Identification of DEMs and DEGs
As shown in Figure 1(b), 1(c), 2(a), and 2(b), there were 2006 miRNAs in GSE75422 data sets, and then 29 DEMs were screened out (17 upregulated miRNAs and 12 downregulated miRNAs in decidualized ECSCs). There were 21754 mRNAs in GSE75423 data sets, and then, 523 DEGs were screened out (272 upregulated mRNAs and 251 down-regulated mRNAs in decidualized ECSCs).
3.2. miRNA Target Gene Prediction
Through three online databases, twenty-two miRNAs related to 606 mRNA pairs were obtained (as shown in the supplement (see available here)).
3.3. Screening of Overlapping Genes
As shown in Figure 2(c) and Table 1, fourteen overlapping genes were screened out and a miRNA-mRNA network was constructed. Among the miRNA-mRNA regulatory networks, some mRNAs, including TRPS1, IGSF8, IRF2BP2, IGF1R, CELSR3 and PDE4D, were upregulated in decidualized ECSCs, and other mRNAs, including MYBL2, PDCL3, KLF6, FUS, PIP4K2A, ASXL1, POLE4, and DDAH1, were downregulated in decidualized ECSCs. As to miRNAs, these miRNAs, including hsa-miR-30b-5p, hsa-miR-766-3p, hsa-miR-181c-5p, hsa-miR-766-3p, hsa-miR-30b-5p, hsa-miR-7-5p, hsa-miR-7-5p, and hsa-miR-30b-5p, were upregulated in decidualized ECSCs, and some miRNAs, including hsa-miR-155-5p, hsa-miR-7-5p, hsa-miR-155-5p, hsa-miR-378a-3p, hsa-miR-30b-5p, and hsa-miR-18a-5p, were downregulated in decidualized ECSCs.
3.4. Go and KEGG Pathway Enrichment Analysis of Overlapping Genes
Through analysis, one hundred and sixty-six GO terms were enriched, and the first 10 GO terms with the most obvious enrichment are shown in Figure 3(a). GO analysis showed that 14 overlapping genes were mainly enriched in retinoic acid receptor binding, regulation of systemic arterial blood pressure, B cell differentiation, phosphatidylinositol 3-kinase signaling, skeletal system development, nuclear hormone receptor binding, phosphatidylinositol-mediated signaling, inositol lipid-mediated signaling, and regulation of blood pressure. Moreover, seven pathways were enriched. KEGG pathway enrichment analysis indicated 14 overlapping genes were mainly enriched in transcriptional misregulation in cancer, base excision repair, DNA replication, nucleotide excision repair, ovarian steroidogenesis, long-term depression, and longevity regulating pathway-multiple species, as shown in Figure 3(b) and Table 2. In summary, the Go and KEGG pathway enrichment analyses of overlapping genes were significantly enriched in metabolism (retinoic acid receptor binding, phosphatidylinositol-mediated signaling, inositol lipid-mediated signaling, ovarian steroidogenesis and arginine catabolic process, etc.) and immunity (such as B cell differentiation).
3.5. Construction of a miRNA-mRNA Network
As shown in Figure 4, a total of 2 nodes and 1 edge were mapped in the PPI network of the overlapping genes (IGF1R and KLF6). In addition, a miRNA-mRNA network, including 14 mRNAs (e.g., IGF1R, DDAH1, and KLF6) and 9 miRNAs (e.g., hsa-miR-378a-3p, miRNA-766-3p, and hsa-miR-7-5p), was successfully constructed.
EMS is a common gynecological disease in women, which can lead to symptoms such as pelvic pain and female infertility. At the same time, the endometrial tissue undergoes periodic decidualization during the women’s menstrual cycle. It is worth noting that the decidualization of ectopic endometrial tissue in patients with EMS is easily confused with malignant ovarian tumors, and its specific molecular biological mechanism is still unclear. Therefore, an in-depth study of the key genes and mechanisms of ectopic endometrial decidualization is of great significance for the diagnosis and treatment of EMS.
Recently, much attention has been focused on miRNAs, which can regulate gene expression at the post-transcriptional level, thereby further affecting cell proliferation, migration and invasion, signal transduction, autophagy, and apoptosis [11–13]. Meanwhile, bioinformatics, as an emerging discipline, is used to deal with genetic data and identify novel diagnosis markers [14, 15]. However, to date, no researchers have adopted this method to study the mechanism of ectopic endometrial decidualization.
In this study, we employed an integrative methodology to construct a miRNA-mRNA network and analyzed undiscovered pathways possibly regulated by those miRNAs. In our view, this innovative strategy of analysis may help to shed light on the genetic background of the disease, suggesting further molecular investigations in novel pathogenic mechanisms. Firstly, we selected 29 DEMs and 523 DEGs as our subsequent research object. Then, we constructed a miRNA-mRNA network and found 14 overlapping genes in miRNA-mRNA network may participate in the process of decidualization of ECSCs through metabolism (e.g., retinoic acid receptor binding, phosphatidylinositol-mediated signaling, inositol lipid-mediated signaling, ovarian steroidogenesis, and arginine catabolic process) and immunity (such as B cell differentiation). Many immunological factors are known to contribute significantly to the pathogenesis and pathophysiology of EMS, and both chronic local inflammation and autoantibodies in EMS share numerous similarities with autoimmune diseases (AD). Previous studies have shown that soluble chemoattractant proteins expressed in ectopic tissues of patients with EMS can recruit innate immune cells (such as neutrophils, natural killer cells, and macrophages) to accumulate in ectopic endometrial tissues [16, 17]. However, the relationship between decidualization of ectopic endometrium and immunity has not been reported. Our results further clarify the role of immunity in EMS and suggest that the immune system may play an important role in the decidualization of the ectopic endometrium.
In terms of metabolism, many studies have reported that decidualization of eutopic endometrium is related to metabolism, such as PKM2 and BPA [18, 19]. However, molecular biological processes related to metabolism in the process of decidualization of ECSCs have not been reported yet. Our results suggest that decidualization of ectopic endometrium may also be related to retinoic acid receptor (RAR). It is well known that RAR can regulate gene expression after binding with retinoic acid (RA) to maintain tissue differentiation. In endometriotic stromal cells, decreased expression of RAR leads to apoptosis and reduces cell survival . At the same time, in the process of decidualization, there is apoptosis in decidual cells. Therefore, this provides us with some enlightenment. We speculated that RAR may be related to the presence of decidual cells in the process of decidualization of ECSCs.
In the miRNA-mRNA network, miRNA-30d-5p, miRNA-30b-5p, miRNA-181c-5p, and miRNA-766-3p were highly expressed in decidual ECSCs, while PIP4K2A, MYBL2, DDAH1, KLF6, FUS, and PDCL3, the target genes of those miRNAs were low expressed in decidual ECSCs. What is more, miRNA-378a-3p, miRNA-7-5p, miRNA-55-5p, miRNA-18a-5p, and miRNA-18b-5p were low expressed in decidual ECSCs, while IGF1R, PDE4D, IGSF8, IRF2BP2, and TRPS1, the target genes of those miRNAs were highly expressed in decidual ECSCs. This result showed that these miRNAs may target some mRNAs that correspond to them and play a role in decidualization of ECSCs.
Among the 14 overlapping genes, we found 6 downregulated mRNAs and 8 upregulated mRNAs in decidualized ECSCs. Some of them have been reported to play important roles in the development of tumor proliferation, apoptosis, and metastasis, such as IGF1R , MYBL2 , POLE , and DDAH1 . Some of them were involved in various inflammatory and immune responses, such as PDE4D  and IRF2BP2 . It is well known that phosphodiesterases (PDEs) can hydrolyze the second messenger (cAMP) in the cell, which further plays an important role in regulating cell activities. PDE4D is a member of this large family of PDEs. The protein encoded by the PDE4D can degrade cAMP. PDE4D could regulate the function of cells in the inflammatory response through cAMP-dependent pathways, such as activation and proliferation of T lymphocytes, release of inflammatory factors, and aggregation of monocytes and neutrophils [27–29]. At the same time, it is worth noting that the decidual process is initiated through the cAMP signaling pathway. This further supports our prediction that PDE4D may participate in decidualization by regulating the inflammatory response. In addition, some genes were related to metabolism and signal transduction, such as IRF2BP2 , PIP4K2A , and KLF6 . PIP4K2A and KLF6 were related to adipogenesis. Meanwhile, in the process of camp-induced decidualization of ESCs, lipid increased. Therefore, our results suggested that these overlapping genes may play a role in the process of endometrial decidualization by regulating metabolism through some biological processes.
Nowadays, many studies have investigated the role of miRNAs in EMS [33, 34]. In our study, 9 miRNAs were screened out (miRNA-378a-3p, miRNA-7-5p, miRNA-55-5p, miRNA-18a-5p, and miRNA-18b-5p were low expressed in decidual ECSCs, and miRNA-30d-5p, miRNA-30b-5p, miRNA-181c-5p, and miRNA-766-3p were highly expressed in decidual ECSCs). According to previous research reports, downregulation of mir-378a-3p , miR-181b-5p , and miR-155  is beneficial to the formation of decidualization. This is in agreement with our results. Therefore, we speculate that these 3 miRNAs may also be involved in decidualization of ECSCs. However, it needs to be verified by experiments. It is worth noting that the relationship between the other 6 miRNAs and decidualization or EMS has not been reported. Recent research shows that these 6 miRNAs participate in the occurrence and development of various diseases , such as tumor growth , metastasis and cell differentiation, through immunity, and metabolism . This study may provide new insights for the study of these 6 miRNAs in decidualization.
In conclusion, through microarray of miRNA-mRNA expression profiles, we discovered the miRNAs, potentially regulated genes, and possible pathways associated with decidualization of ECSCs. The molecular roles that these dysregulated miRNAs play in EMS were not completely elucidated. Our study, however, had some obvious limitations. The further functional experiments are needed to back and validate the function of these miRNAs in the decidualization of ECSCs.
The expression data associated with this article is available on GEO databases (https://www.ncbi.nlm.nih.gov/geo/).
The funder had no role in the study design, data collection, and analysis, except for bioinformatics training, writing the manuscript, and decision to publish.
Conflicts of Interest
The authors declare that they have no competing interests.
JZL and BZ performed the comparative analysis using bioinformatics tools. CY participated in the data analysis and discussion. JZL and BZ interpreted the results and wrote the manuscript. QHC organized and supervised the project. All authors read and approved the final manuscript. Junzui Li and Bin Zhao contributed equally to this work.
This work was financially supported by the National Key R&D Program of China (SQ2017YFSF080005) and the National Science Foundation of China (No. 81871145).
The first table named “miRNA-mRNA pairs” is a supplement to the manuscript. The second table named “GO enrichment analysis” and the third table named “KEGG enrichment analysis” are used. (Supplementary Materials)
- L. C. GIUDICE and L. C. KAO, “Endometriosis,” The Lancet, vol. 364, no. 9447, pp. 1789–1799, 2004.
- B. GELLERSEN and J. J. BROSENS, “Cyclic decidualization of the human endometrium in reproductive health and failure,” Endocrine reviews, vol. 35, no. 6, pp. 851–905, 2014.
- R. Navarro, L. Poder, D. Sun, and P. Jha, “Endometriosis in pregnancy,” Abdominal Radiology, vol. 45, no. 6, pp. 1741–1753, 2020.
- B. Gellersen, I. Brosens, and J. Brosens, “Decidualization of the human endometrium: mechanisms, functions, and clinical perspectives,” Seminars in reproductive medicine, vol. 25, no. 6, pp. 445–453, 2007.
- R. Focarelli, A. Luddi, V. De Leo et al., “Dysregulation of GdA expression in endometrium of women with endometriosis: implication for endometrial receptivity,” Reproductive Sciences, vol. 25, no. 4, pp. 579–586, 2017.
- J. I. Ahn, J.-Y. Yoo, T. H. Kim et al., “cAMP-response element-binding 3-like protein 1 (CREB3L1) is required for decidualization and its expression is decreased in women with endometriosis,” Current Molecular Medicine, vol. 16, no. 3, pp. 276–287, 2016.
- R.-W. Su, M. R. Strug, N. R. Joshi et al., “Decreased Notch pathway signaling in the endometrium of women with endometriosis impairs decidualization,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 3, pp. E433–E442, 2015.
- H.-J. Cho, M.-O. Baek, S. A. Khaliq et al., “Microgravity inhibits decidualization via decreasing Akt activity and FOXO3a expression in human endometrial stromal cells,” Scientific Reports, vol. 9, no. 1, p. 12094, 2019.
- Y. Aoyagi, K. Nasu, K. Kai et al., “Decidualization differentially regulates microRNA expression in eutopic and ectopic endometrial stromal cells,” Reproductive Sciences, vol. 24, no. 3, pp. 445–455, 2017.
- M. E. Ritchie, B. Phipson, D. Wu et al., “limma powers differential expression analyses for RNA-sequencing and microarray studies,” Nucleic Acids Research, vol. 43, no. 7, p. e47, 2015.
- M. Ashrafizadeh, H. L. Ang, E. R. Moghadam et al., “MicroRNAs and their influence on the ZEB family: mechanistic aspects and therapeutic applications in cancer therapy,” Biomolecules, vol. 10, no. 7, p. 1040, 2020.
- A. Vishnoi and S. Rani, “MiRNA biogenesis and regulation of diseases: an overview,” Methods Molecular Biology, vol. 1509, pp. 1–10, 2017.
- K. Saliminejad, H. R. K. Khorshid, S. S. Fard, and S. H. Ghaffari, “An overview of microRNAs: biology, functions, therapeutics, and analysis methods,” Journal of Cellular Physiology, vol. 234, no. 5, pp. 5451–5465, 2019.
- Z. Tao, A. Shi, R. Li, Y. Wang, X. Wang, and J. Zhao, “Microarray bioinformatics in cancer- a review,” Journal of B.U.ON, vol. 22, no. 4, pp. 838–843, 2017.
- N. J. Mulder, E. Adebiyi, M. Adebiyi et al., “Development of bioinformatics infrastructure for genomics research,” Global Heart, vol. 12, no. 2, pp. 91–98, 2019.
- G. Anderson, “Endometriosis pathoetiology and pathophysiology: roles of vitamin A, estrogen, immunity, adipocytes, gut microbiome and melatonergic pathway on mitochondria regulation,” Biomolecular Concepts, vol. 10, no. 1, pp. 133–149, 2019.
- M. Králíčková, L. Fiala, P. Losan, P. Tomes, and V. Vetvicka, “Altered immunity in endometriosis: what came first?” Immunological Investigations, vol. 47, no. 6, pp. 569–582, 2018.
- Y. Su, S. Guo, C. Liu et al., “Endometrial pyruvate kinase M2 is essential for decidualization during early pregnancy,” Journal of Endocrinology, vol. 245, no. 3, pp. 357–368, 2020.
- Y. Xiong, X. Wen, H. Liu, M. Zhang, and Y. Zhang, “Bisphenol a affects endometrial stromal cells decidualization, involvement of epigenetic regulation,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 200, article 105640, 2020.
- M. E. Pavone, S. Reierstad, H. Sun, M. Milad, S. E. Bulun, and Y.-H. Cheng, “Altered retinoid uptake and action contributes to cell survival in endometriosis,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 11, pp. E300–E309, 2010.
- B. He, S. Xia, and Z. Zhang, “NudCD1 promotes the proliferation and metastasis of non-small cell lung cancer cells through the activation of IGF1R-ERK1/2,” Pathobiology, pp. 1–10, 2020.
- G. Rafatian, M. Kamkar, S. Parent et al., “Mybl 2 rejuvenates heart explant-derived cells from aged donors after myocardial infarction,” Aging Cell, vol. 19, no. 7, 2020.
- V. Kryklyva, E. ter Linden, L. I. Kroeze et al., “Medullary pancreatic carcinoma due to somatic POLE mutation: a distinctive pancreatic carcinoma with marked long-term survival,” Pancreas, vol. 49, no. 7, pp. 999–1003, 2020.
- Z. Huang, Y. Ma, P. Zhang, J. Si, Y. Xiong, and Y. Yang, “Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma,” Anticancer Drugs, vol. 31, no. 1, pp. 44–54, 2020.
- M.-Y. Lu, J.-R. Wu, R.-B. Liang et al., “Upregulation of miR-219a-5p decreases cerebral ischemia/reperfusion injury in vitro by targeting Pde4d,” Journal of Stroke and Cerebrovascular Diseases, vol. 29, no. 6, article 104801, 2020.
- J. Fang, Y.‐. X. Ji, P. Zhang et al., “Hepatic IRF2BP2 mitigates nonalcoholic fatty liver disease by directly repressing the transcription of ATF3,” Hepatology, vol. 71, no. 5, pp. 1592–1608, 2020.
- F. J. Nunez, N. A. Schulte, D. M. Fogel et al., “Agonist-specific desensitization of PGE2-stimulated cAMP signaling due to upregulated phosphodiesterase expression in human lung fibroblasts,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 393, no. 5, pp. 843–856, 2020.
- D. Mika, P. Bobin, M. Lindner et al., “Synergic PDE3 and PDE4 control intracellular cAMP and cardiac excitation-contraction coupling in a porcine model,” Journal of Molecular and Cellular Cardiology, vol. 133, pp. 57–66, 2019.
- H. Li, C. Fan, C. Feng et al., “Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity,” British Journal of Pharmacology, vol. 176, no. 13, pp. 2209–2226, 2019.
- A. B. M. K. Manjur, J. K. Lempiäinen, M. Malinen, J. J. Palvimo, and E. A. Niskanen, “IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 192, article 105382, 2019.
- M. R. Lundquist, M. D. Goncalves, R. M. Loughran et al., “Phosphatidylinositol-5-phosphate 4-kinases regulate cellular lipid metabolism by facilitating autophagy,” Molecular Cell, vol. 70, no. 3, pp. 531–544.e9, 2018.
- Z. Junjvlieke, C.‐. G. Mei, R. Khan et al., “Transcriptional regulation of bovine elongation of very long chain fatty acids protein 6 in lipid metabolism and adipocyte proliferation,” Journal of Cellular Biochemistry, vol. 120, no. 8, pp. 13932–13943, 2019.
- C.-l. Gu, Z. Zhang, W.-s. Fan et al., “Identification of micro RNAs as potential biomarkers in ovarian endometriosis,” Reproductive Sciences, vol. 27, no. 9, pp. 1715–1723, 2020.
- L. Zhao, C. Gu, M. Ye et al., “Integration analysis of microRNA and mRNA paired expression profiling identifies deregulated microRNA-transcription factor-gene regulatory networks in ovarian endometriosis,” Reproductive Biology and Endocrinology, vol. 16, no. 1, p. 4, 2018.
- L. Hong, T. Yu, H. Xu et al., “Down-regulation of miR-378a-3p induces decidual cell apoptosis: a possible mechanism for early pregnancy loss,” Human Reproduction, vol. 33, no. 1, pp. 11–22, 2018.
- A. Graham, J. Holbert, and W. B. Nothnick, “miR-181b-5p modulates cell migratory proteins, tissue inhibitor of metalloproteinase 3, and annexin A2 during in vitro decidualization in a human endometrial stromal cell line,” Reproductive Sciences, vol. 24, no. 9, pp. 1264–1274, 2016.
- C. Estella, I. Herrer, J. M. Moreno-Moya et al., “miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro,” PLoS One, vol. 7, no. 7, article e41080, 2012.
- Y. Duan, Y. Zhang, W. Peng, P. Jiang, Z. Deng, and C. Wu, “MiR-7-5p and miR-4 51 as diagnostic biomarkers for papillary thyroid carcinoma in formalin-fixed paraffin-embedded tissues,” Pharmazie, vol. 75, no. 6, pp. 266–270, 2020.
- G. Wu, Y. Sun, Z. Xiang et al., “Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression,” Cell Death & Disease, vol. 10, no. 2, p. 37, 2019.
- A. Matarese, J. Gambardella, A. Lombardi, X. Wang, and G. Santulli, “miR-7 regulates GLP-1-mediated insulin release by targeting β-Arrestin 1,” Cells, vol. 9, no. 7, p. 1621, 2020.
Copyright © 2020 Junzui Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.